Jeena Sikho Lifecare

    JSLL
    Consumer
    ₹296.35
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹3,684 Cr

    P/E
    15.61
    Day range
    ₹293.50 – ₹305.00
    52-week range
    ₹280.00 – ₹809.00
    Volume
    9.12 L
    Open
    ₹299.95
    Prev close
    ₹299.95

    Latest results · Q2 FY27(consolidated)Revenue ₹235 Cr+23.9%Profit ₹37 Cr-37.7%Margin 15.6%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 39 / 100

    Factor percentiles

    Value64
    Quality81
    Momentum1
    Low volatility12

    Derived metrics

    Earn. yield
    6.4%
    Graham no.
    ₹124.14
    vs Graham
    -58.1%
    ROE ÷ P/B
    8.2%
    12-1 mom.
    -46.7%
    Return / vol
    -1.08
    Magic Formula
    #10
    FCF yield
    6.0%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 90 in Consumer
    Largest Consumer companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Titan CompanyTITAN₹4.12 L Cr58.6723.8337.1%21.0%14.0%1.51+10.1%
    Asian PaintsASIANPAINT₹2.47 L Cr51.1411.2321.6%26.0%16.0%0.21+16.9%
    Avenue SupermartsDMART₹2.26 L Cr72.598.6012.9%17.0%7.0%0.16+17.8%
    TrentTRENT₹1.70 L Cr89.7321.7527.7%28.0%18.0%0.30+21.9%
    Lenskart SolutionsLENSKART₹1.27 L Cr162.3313.716.8%8.0%22.0%0.37+35.7%
    The Indian Hotels CompanyINDHOTEL₹1.25 L Cr56.359.2918.6%17.0%28.0%0.25+21.7%
    MeeshoMEESHO₹1.17 L Cr188.6427.61-46.6%-40.0%-6.0%0.01+34.4%
    Jeena Sikho LifecareJSLL₹3,684 Cr15.617.4561.4%64.0%31.0%0.32+23.7%
    Sector median₹10,665 Cr40.834.8313.0%15.0%12.5%0.27+19.1%

    Sector as classified in the tracked universe; medians use every tracked Consumer company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 7h ago

    Headlines about Jeena Sikho Lifecare from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    18.0
    Price / Book
    7.12
    ROE (FY26)
    61.4%
    ROCE (latest year)
    64%
    Dividend yield
    1.45%

    Moving averages (NSE)

    20-day
    ₹338.59
    Price below
    50-day
    ₹415.81
    Price below
    200-day
    ₹565.24
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +76.0%
    Profit 3Y CAGR
    +172.3%
    Revenue YoY (Sep 2026)
    +23.7%
    Profit YoY (Sep 2026)
    -37.3%
    Operating margin
    31.0%
    Net margin
    15.7%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr100 Cr200 Cr300 Cr
    • Revenue
    • Net profit

    Operating margin

    Jun 2024 (S)Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%25%50%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Sept '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • Public
    • FII
    • DII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2019 (S)Mar 2020 (S)Mar 2021 (S)Mar 2022Mar 2023Mar 2025Mar 2026-400 Cr-200 Cr0 Cr200 Cr400 Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY20FY21FY22FY23FY25FY260%20%40%60%80%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr200 Cr400 Cr600 Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2019 (S)Mar 2020 (S)Mar 2021 (S)Mar 2022Mar 2023Mar 2025Mar 2026Sep 20260x1x2x

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemJun 2024 (S)Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales100114116139174190222216224235
    Expenses757486939698121138132163
    Operating Profit254030467992101789272
    OPM %25%35%26%33%45%48%45%36%41%31%
    Other Income3300113314-2
    Interest1243243434
    Depreciation5689101011161516
    Profit before tax21351834697989618850
    Tax %23%25%26%25%25%25%25%26%25%26%
    Net Profit16271325515967456637
    EPS in Rs₹1.30₹2.14₹1.06₹2.04₹4.13₹4.73₹5.36₹3.63₹5.31₹2.95

    From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days32

    +15 days since Mar 2020 (S)

    Inventory Days81

    -234 days since Mar 2020 (S)

    Days Payable92

    -76 days since Mar 2020 (S)

    Cash Conversion Cycle20

    -143 days since Mar 2020 (S)

    Working Capital Days15

    +30 days since Mar 2020 (S)

    Strengths, risks & growth

    Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

    Strengths

    • Company is expected to give good quarter
    • Debtor days have improved from 49.0 to 31.8 days.
    • Company's working capital requirements have reduced from 21.2 days to 14.6 days

    Risks

    • Stock is trading at 7.46 times its book value
    • Promoter holding has decreased over last 3 years: -4.24%

    Compounded Sales Growth

    10 Years
    —
    5 Years
    —
    3 Years
    +58%
    TTM
    +45%

    Compounded Profit Growth

    10 Years
    —
    5 Years
    —
    3 Years
    +88%
    TTM
    +44%

    Stock Price CAGR

    10 Years
    —
    5 Years
    —
    3 Years
    +29%
    1 Year
    -57%

    Return on Equity

    10 Years
    —
    5 Years
    —
    3 Years
    —
    Last Year
    +61%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter63.62%63.62%63.62%63.67%+0.05 pp
    FII6.31%6.17%4.78%4.49%-0.29 pp
    DII0.11%0.46%0.36%0.53%+0.17 pp
    Public29.97%29.77%31.24%31.29%+0.05 pp

    Filed with NSE for Sept 2026: promoters 63.67%, public 36.33%

    Analysts & fund holdings

    100%
    100% recommend buy
    1 analysts cover the stock
    Valuation vs Pharmaceuticals
    P/E15.6 vs 45.2
    Sector P/B6.05
    Beta0.53

    Who holds the shares, quarter by quarter

    Mutual funds 0.10% (0.00 pp)
    Aug 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters63.7%
    • Foreign institutions4.5%
    • Mutual funds0.1%
    • Insurance0.0%
    • Other domestic institutions0.4%
    • Retail15.8%
    • Others15.5%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Motilal Oswal Nifty Microcap 250 Index Fund0.12%0.19%-0.11 pp
    Groww Nifty Total Market Index Fund0.00%0.01%-0.01 pp
    Angel One Nifty Total Market Index Fund0.00%0.01%-0.01 pp
    Bandhan Nifty Total Market Index Fund0.00%0.01%-0.01 pp
    Mirae Asset Nifty Total Market Index Fund0.00%0.01%-0.01 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    55.1%
    Downside volatility
    55.4%
    Worst 5% of days
    5.3%
    Average of that tail
    8.5%
    Max drawdown (1Y)
    64.6%
    Below its peak
    64.6%

    Against the market

    Beta vs Nifty 50
    1.19
    Correlation
    0.29
    Relative strength (3M)
    -46.6%
    ATR (14)
    7.2%

    Return

    Return 1M
    -23.7%
    Return 3M
    -42.7%
    Return 6M
    -53.1%
    Return 1Y
    -59.3%
    vs 200-day average
    -47.6%

    Momentum

    RSI (14) · oversold
    29.7
    MACD histogram
    0.48
    Stochastic %K
    17.8
    ADX (14)
    42.4
    +DI / −DI
    14.8 / 42.9
    Money flow index
    26.1

    Participation

    Delivery (20d avg)
    43.0%
    vs its 60-day baseline
    -1.9 pts
    Volume vs 20-day
    -0.0σ
    Close vs day's VWAP
    -0.6%
    52-week position
    0 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 31 Mar 2026.

    Computed

    No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.

    Free cash flow
    ₹220 Cr
    FCF yield
    6.0%
    Cash conversion
    1.14
    Accruals ratio
    -0.048
    Net debt
    ₹111 Cr
    Net debt / equity
    0.24
    EV / sales
    4.23
    Capex intensity
    4.2%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Corporate actions

    • dividend
      ₹4.50

      Dividend - Rs 4.50 Per Share

      21 Sept 2026
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1.10 Per Share

      22 Sept 2025
      ex-date

    Company announcements

    Company Update
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    Allotment of 23,374 Equity Shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 ("ESOS 2024")

    Company Update
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please refer to the attached pdf

    Company Update
    Intimation For Launch Of New Products

    Launch of New Products

    Company Update
    Receipt Of NABH Accreditation For Raipur Hospital.

    NABH Accreditation for Raiput Hospital

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer's Report and Voting Result of 9th AGM of the company Held on 28.09.2026

    Insider Trading / SAST
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover

    Company Update
    Disclosure Under Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Disclosure under Regulation 29(2), details as attached in the PDF.

    Company Update
    Disclosure Under Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Disclosure under Regulation 29(2), details as attached in the PDF.

    Insider Trading / SAST
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of 9th AGM of the Company held on 28.09.2026

    Insider Trading / SAST
    Closure of Trading Window

    Intimation for Closure of Trading Window for the Quarter and half year ended 30.09.2026

    Company Update
    Intimation Of In-Principle Approval Received From BSE Limited For Listing Of Up To A Maximum Of 6,50,000 Equity Shares Of Rs. 2/-Each Of Jeena Sikho Lifecare Limited To Be Issued Under Jeena Sikho Employees Stock Option Scheme, 2024 ('ESOS 2024').

    Intimation of In-Principle Approval from BSE Limited under Jeena sikho Employees Stock Option Scheme, 2024 (ESOS 2024)

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update
    Intimation For Launch Of New Products

    Launch of New products.

    Company Update
    Intimation Regarding Postponement In Commencement Of Commercial Operations At The New Hospital Facility In Lucknow, Uttar Pradesh

    Please refer to the attached PDF for details.

    Filed with BSE (scrip 544476); the last 45 days. Documents open at bseindia.com.

    Documents

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 15 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Jeena Sikho Lifecare: common questions

    Answered from the figures on this page.

    Jeena Sikho Lifecare last traded at ₹296.35 (NSE, as of 18 Nov 2026). The last session moved it down 1.20%.

    Jeena Sikho Lifecare is valued at about ₹3,684 crore (NSE, as of 18 Nov 2026).

    Jeena Sikho Lifecare trades at a price-to-earnings ratio of 15.61 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Jeena Sikho Lifecare has traded between ₹280.00 and ₹809.00 over the past 52 weeks, to 18 Nov 2026. It is currently 3% of the way up that range.

    Jeena Sikho Lifecare (JSLL) is classified under Consumer on this site's screener.